Research is being conducted on the use of positron emission tomography/computed tomography in ovarian cancer, exploring its current status and future potential. Various studies and reviews are examining emerging radiopharmaceuticals, imaging techniques, and biomarkers to improve diagnosis and treatment of ovarian cancer. The field appears to be advancing with new assessments and meta-analyses of different imaging modalities, including PET/CT and MRI, being reported.